about
Aloesin as a medical food ingredient for systemic oxidative stress of diabetesNeuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets.Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy.Diabetes and alpha lipoic Acid.Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathyBerberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathySelective cytotoxicity and combined effects of camptothecin or paclitaxel with sodium-R-alpha lipoate on A549 human non-small cell lung cancer cells.Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: RAdvanced glycation endproducts and their pathogenic roles in neurological disorders.Diabetic neuropathy: cellular mechanisms as therapeutic targets.Cardiovascular autonomic neuropathies as complications of diabetes mellitus.Therapeutic applications of lipoic acid: a patent review (2011 - 2014).Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons.Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.Heme oxygenase-1 inhibits neuropathic pain in rats with diabetic mellitus.Antioxidant strategies in the management of diabetic neuropathy.A Caenorhabditis elegans Model Elucidates a Conserved Role for TRPA1-Nrf Signaling in Reactive α-Dicarbonyl Detoxification.The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy.NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes.Targeting oxidative stress through antioxidants in diabetes mellitus.Metabolic Syndrome and Neuroprotection.R(+)-Thioctic Acid Effects on Oxidative Stress and Peripheral Neuropathy in Type II Diabetic Patients: Preliminary Results by Electron Paramagnetic Resonance and Electroneurography.
P2860
Q26798991-2B6F515C-5136-4A46-84DE-09DDC3D4DDD8Q33614346-02A0C362-E4FE-4D5E-B206-0C40FEC88D5DQ34218901-142F3BBF-75AD-416A-AEED-DAFCA7E8CE1AQ35564911-F00C9109-A671-49E6-BF24-D4FD585ECE42Q36649993-0C973BED-E59A-4B6E-9454-CAFD5BE693D5Q36933488-62AB66CB-75AB-4A2C-8040-308FB928DBEFQ37660148-BD669E67-B042-4D36-AAA7-239F5D21857EQ37712129-C0F83E88-3CEF-419C-BCD4-A92BE5ABF792Q37800424-9E7E8317-D9B2-4D2C-AE75-D30C64488679Q37930962-52ADD5AA-E733-4FA8-AFF2-17AF1CD63F7BQ37988796-027B6473-57C8-4CE3-8A61-047BC3672B31Q38237714-446F817D-F700-4F89-9D7E-F7F017A6DA4AQ38957347-EF206F23-FB0B-4A40-B5BB-E08D9C4B2DB0Q39414338-349B01B5-50E8-4F8A-8FBF-6555DF2F02CDQ42100063-4A7814A3-7CCA-4541-B4F8-2386416193C3Q42180667-36000A62-842F-40DB-BE30-819DFB78A767Q44475765-3C9849A8-5B98-4E07-BA1C-93D1DB528590Q46248218-EA61204F-1E47-4EED-B899-4D2E825583ECQ47094741-17BCDCEB-9AAB-4132-8A35-EC47407D3818Q47235697-4880CE0A-42DF-46A5-8E21-E28283C7263EQ53687232-F0575E15-8265-48D4-BEF8-F08D4E282AD9Q54967603-65720E69-6CA3-48A2-A9CE-8BF66C2BB391
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alpha-lipoic Acid and diabetic neuropathy.
@en
Alpha-lipoic Acid and diabetic neuropathy.
@nl
type
label
Alpha-lipoic Acid and diabetic neuropathy.
@en
Alpha-lipoic Acid and diabetic neuropathy.
@nl
prefLabel
Alpha-lipoic Acid and diabetic neuropathy.
@en
Alpha-lipoic Acid and diabetic neuropathy.
@nl
P2093
P2860
P356
P1476
Alpha-lipoic Acid and diabetic neuropathy.
@en
P2093
Angelos Evangelopoulos
Natalia Vallianou
Pavlos Koutalas
P2860
P304
P356
10.1900/RDS.2009.6.230
P577
2009-12-30T00:00:00Z